Stryker Upgraded to Buy at BofA Securities
<p>BofA Securities analysts upgraded <a href='https://financialmodelingprep.com/financial-summary/SYK'>Stryker (NYSE:SYK)</a> from a Neutral rating to a Buy, while also raising the price target from $310.00 to $315.00. </p>
<p>The analysts' rationale for the upgrade centers on several factors, including Stryker's improved outlook on profit margins, a positive product cycle that could boost revenue growth, strong capital visibility through 2024, a favorable orthopedic segment outlook, and the potential for enhanced operating margins, which could lead to a 2% increase in earnings per share. </p>
<p>As a result, the new price target reflects the same 27x multiple for 2024 earnings but with slightly higher expected EPS.</p>

NYSE:SYK